Video: Perturb PBMC - Functional Proteomics of the PBMC Secretome
Runtime: 8:33
Perturbation screens are reshaping drug discovery, turning observation into causal, data-driven insight.
Most rely on RNA or imaging readouts; affordable, yet poor proxies for functional protein activity. To interrogate function, you have to measure proteins. But the protein layer has always been hard to access at scale, expensive, slow, and complex. At Nomic we’ve been changing that—delivering proteome-wide functional insights at genomic costs.
Hosted by Nathaniel Robichaud, PhD, Partnerships Lead at Nomic, this short video explores findings from our large-scale PBMC screen and their implications for multiple sclerosis, and details how you can explore the dataset yourself to draw your own conclusions.
Video: Perturb PBMC - Functional Proteomics of the PBMC Secretome
Subscribe to Updates
Get the latest insights and updates delivered straight to your inbox weekly.
Runtime: 8:33
Perturbation screens are reshaping drug discovery, turning observation into causal, data-driven insight.
Most rely on RNA or imaging readouts; affordable, yet poor proxies for functional protein activity. To interrogate function, you have to measure proteins. But the protein layer has always been hard to access at scale, expensive, slow, and complex. At Nomic we’ve been changing that—delivering proteome-wide functional insights at genomic costs.
Hosted by Nathaniel Robichaud, PhD, Partnerships Lead at Nomic, this short video explores findings from our large-scale PBMC screen and their implications for multiple sclerosis, and details how you can explore the dataset yourself to draw your own conclusions.
Video: Perturb PBMC - Functional Proteomics of the PBMC Secretome
Read the full publication
Runtime: 8:33
Perturbation screens are reshaping drug discovery, turning observation into causal, data-driven insight.
Most rely on RNA or imaging readouts; affordable, yet poor proxies for functional protein activity. To interrogate function, you have to measure proteins. But the protein layer has always been hard to access at scale, expensive, slow, and complex. At Nomic we’ve been changing that—delivering proteome-wide functional insights at genomic costs.
Hosted by Nathaniel Robichaud, PhD, Partnerships Lead at Nomic, this short video explores findings from our large-scale PBMC screen and their implications for multiple sclerosis, and details how you can explore the dataset yourself to draw your own conclusions.
Video: Perturb PBMC - Functional Proteomics of the PBMC Secretome
Runtime: 8:33
Perturbation screens are reshaping drug discovery, turning observation into causal, data-driven insight.
Most rely on RNA or imaging readouts; affordable, yet poor proxies for functional protein activity. To interrogate function, you have to measure proteins. But the protein layer has always been hard to access at scale, expensive, slow, and complex. At Nomic we’ve been changing that—delivering proteome-wide functional insights at genomic costs.
Hosted by Nathaniel Robichaud, PhD, Partnerships Lead at Nomic, this short video explores findings from our large-scale PBMC screen and their implications for multiple sclerosis, and details how you can explore the dataset yourself to draw your own conclusions.
Watch Video Now
Video: Perturb PBMC - Functional Proteomics of the PBMC Secretome
Runtime: 8:33
Perturbation screens are reshaping drug discovery, turning observation into causal, data-driven insight.
Most rely on RNA or imaging readouts; affordable, yet poor proxies for functional protein activity. To interrogate function, you have to measure proteins. But the protein layer has always been hard to access at scale, expensive, slow, and complex. At Nomic we’ve been changing that—delivering proteome-wide functional insights at genomic costs.
Hosted by Nathaniel Robichaud, PhD, Partnerships Lead at Nomic, this short video explores findings from our large-scale PBMC screen and their implications for multiple sclerosis, and details how you can explore the dataset yourself to draw your own conclusions.
Download resource
Get the latest insights and updates delivered straight to your inbox weekly.
Video: Perturb PBMC - Functional Proteomics of the PBMC Secretome
Get the latest insights and updates delivered straight to your inbox weekly.
Runtime: 8:33
Perturbation screens are reshaping drug discovery, turning observation into causal, data-driven insight.
Most rely on RNA or imaging readouts; affordable, yet poor proxies for functional protein activity. To interrogate function, you have to measure proteins. But the protein layer has always been hard to access at scale, expensive, slow, and complex. At Nomic we’ve been changing that—delivering proteome-wide functional insights at genomic costs.
Hosted by Nathaniel Robichaud, PhD, Partnerships Lead at Nomic, this short video explores findings from our large-scale PBMC screen and their implications for multiple sclerosis, and details how you can explore the dataset yourself to draw your own conclusions.